Global Glaucoma Aqueous Shunt Supply, Demand and Key Producers, 2026-2032
Description
The global Glaucoma Aqueous Shunt market size is expected to reach $ 3093 million by 2032, rising at a market growth of 11.8% CAGR during the forecast period (2026-2032).
A glaucoma drainage implant is a small device placed in the eye to treat glaucoma. There are many different ways to treat glaucoma. In addition to conventional and laser surgery, there are a variety of drugs to lower intraocular pressure (IOP). If these methods alone fail, doctors may suggest implants.
It is understood that glaucoma is an irreversible blinding eye disease that is highly harmful and irreversible. Glaucoma brings heavy economic burdens and physiological and psychological distress to patients and society.
Glaucoma blindness is a chronic process. Early detection and reasonable and effective treatment can avoid blindness. Lowering intraocular pressure to treat open-angle glaucoma (POAG) is currently the only proven effective method to slow the progression of glaucoma. For every 1 mmHg decrease in intraocular pressure, the risk of glaucoma progression is reduced by 10%. The European, American and Asia-Pacific Glaucoma Associations as well as my country's glaucoma diagnosis and treatment guidelines all recommend the setting of target intraocular pressure. The main methods of treating glaucoma in my country include drugs, lasers and surgery. However, due to the complexity of risk factors, target intraocular pressures are not the same, and individuals have different responses to treatment. It has been reported that one-third of patients do not meet the target intraocular pressure, which means that they will find it difficult to maintain good vision and quality of life during their lifetime. Therefore, it is urgent to develop new methods to solve this problem. Internationally, new, minimally invasive, and biocompatible drainage devices provide more options and better solutions for glaucoma treatment.
Glaucoma aqueous shunts are implanted in the eye to establish a new aqueous humor outflow path from the anterior chamber (the area inside the eye filled with aqueous humor) to the subconjunctival space (the area between the sclera and conjunctiva). The aqueous humor is drained to the subconjunctival space through the shunt, forming a filtration bleb, thereby reducing the intraocular pressure
Market development trend
Technological innovation: With the continuous advancement of science and technology, glaucoma shunts will continue to introduce new technologies and new materials to improve product performance and safety. For example, the integration of intelligent technology will make glaucoma shunts more accurate and efficient.
Personalized treatment: With the improvement of medical level and the diversification of patient needs, personalized treatment will become an important development direction of the glaucoma shunt market. Enterprises need to provide customized products and services according to the specific conditions of patients to meet their personalized needs.
Internationalization strategy: With the development of global economic integration, the demand for glaucoma shunts in the international market is also increasing. Enterprises will strengthen international cooperation and expand overseas markets to achieve market expansion and global business layout.
This report studies the global Glaucoma Aqueous Shunt production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Glaucoma Aqueous Shunt and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Glaucoma Aqueous Shunt that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Glaucoma Aqueous Shunt total production and demand, 2021-2032, (K Units)
Global Glaucoma Aqueous Shunt total production value, 2021-2032, (USD Million)
Global Glaucoma Aqueous Shunt production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Glaucoma Aqueous Shunt consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Glaucoma Aqueous Shunt domestic production, consumption, key domestic manufacturers and share
Global Glaucoma Aqueous Shunt production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Glaucoma Aqueous Shunt production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Glaucoma Aqueous Shunt production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Glaucoma Aqueous Shunt market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Santen Pharmaceutical, Johnson and Johnson, Advanced Ophthalmic Innovations (AOI), New World Medical, Nova Eye Medical, Glaukos Corp, Alcon, iSTAR Medical, Henan Universe, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Glaucoma Aqueous Shunt market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Glaucoma Aqueous Shunt Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Glaucoma Aqueous Shunt Market, Segmentation by Type:
Trabecular Meshwork-Schlemm Canal Drainage
Subconjunctival Drainage
Others
Global Glaucoma Aqueous Shunt Market, Segmentation by Application:
Hospital
Ophthalmology Clinics
Others
Companies Profiled:
AbbVie
Santen Pharmaceutical
Johnson and Johnson
Advanced Ophthalmic Innovations (AOI)
New World Medical
Nova Eye Medical
Glaukos Corp
Alcon
iSTAR Medical
Henan Universe
Ocular Therapeutix
PolyActiva
Health Guard Biomed
Key Questions Answered:
1. How big is the global Glaucoma Aqueous Shunt market?
2. What is the demand of the global Glaucoma Aqueous Shunt market?
3. What is the year over year growth of the global Glaucoma Aqueous Shunt market?
4. What is the production and production value of the global Glaucoma Aqueous Shunt market?
5. Who are the key producers in the global Glaucoma Aqueous Shunt market?
6. What are the growth factors driving the market demand?
A glaucoma drainage implant is a small device placed in the eye to treat glaucoma. There are many different ways to treat glaucoma. In addition to conventional and laser surgery, there are a variety of drugs to lower intraocular pressure (IOP). If these methods alone fail, doctors may suggest implants.
It is understood that glaucoma is an irreversible blinding eye disease that is highly harmful and irreversible. Glaucoma brings heavy economic burdens and physiological and psychological distress to patients and society.
Glaucoma blindness is a chronic process. Early detection and reasonable and effective treatment can avoid blindness. Lowering intraocular pressure to treat open-angle glaucoma (POAG) is currently the only proven effective method to slow the progression of glaucoma. For every 1 mmHg decrease in intraocular pressure, the risk of glaucoma progression is reduced by 10%. The European, American and Asia-Pacific Glaucoma Associations as well as my country's glaucoma diagnosis and treatment guidelines all recommend the setting of target intraocular pressure. The main methods of treating glaucoma in my country include drugs, lasers and surgery. However, due to the complexity of risk factors, target intraocular pressures are not the same, and individuals have different responses to treatment. It has been reported that one-third of patients do not meet the target intraocular pressure, which means that they will find it difficult to maintain good vision and quality of life during their lifetime. Therefore, it is urgent to develop new methods to solve this problem. Internationally, new, minimally invasive, and biocompatible drainage devices provide more options and better solutions for glaucoma treatment.
Glaucoma aqueous shunts are implanted in the eye to establish a new aqueous humor outflow path from the anterior chamber (the area inside the eye filled with aqueous humor) to the subconjunctival space (the area between the sclera and conjunctiva). The aqueous humor is drained to the subconjunctival space through the shunt, forming a filtration bleb, thereby reducing the intraocular pressure
Market development trend
Technological innovation: With the continuous advancement of science and technology, glaucoma shunts will continue to introduce new technologies and new materials to improve product performance and safety. For example, the integration of intelligent technology will make glaucoma shunts more accurate and efficient.
Personalized treatment: With the improvement of medical level and the diversification of patient needs, personalized treatment will become an important development direction of the glaucoma shunt market. Enterprises need to provide customized products and services according to the specific conditions of patients to meet their personalized needs.
Internationalization strategy: With the development of global economic integration, the demand for glaucoma shunts in the international market is also increasing. Enterprises will strengthen international cooperation and expand overseas markets to achieve market expansion and global business layout.
This report studies the global Glaucoma Aqueous Shunt production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Glaucoma Aqueous Shunt and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Glaucoma Aqueous Shunt that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Glaucoma Aqueous Shunt total production and demand, 2021-2032, (K Units)
Global Glaucoma Aqueous Shunt total production value, 2021-2032, (USD Million)
Global Glaucoma Aqueous Shunt production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Glaucoma Aqueous Shunt consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Glaucoma Aqueous Shunt domestic production, consumption, key domestic manufacturers and share
Global Glaucoma Aqueous Shunt production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Glaucoma Aqueous Shunt production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Glaucoma Aqueous Shunt production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Glaucoma Aqueous Shunt market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, Santen Pharmaceutical, Johnson and Johnson, Advanced Ophthalmic Innovations (AOI), New World Medical, Nova Eye Medical, Glaukos Corp, Alcon, iSTAR Medical, Henan Universe, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Glaucoma Aqueous Shunt market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Glaucoma Aqueous Shunt Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Glaucoma Aqueous Shunt Market, Segmentation by Type:
Trabecular Meshwork-Schlemm Canal Drainage
Subconjunctival Drainage
Others
Global Glaucoma Aqueous Shunt Market, Segmentation by Application:
Hospital
Ophthalmology Clinics
Others
Companies Profiled:
AbbVie
Santen Pharmaceutical
Johnson and Johnson
Advanced Ophthalmic Innovations (AOI)
New World Medical
Nova Eye Medical
Glaukos Corp
Alcon
iSTAR Medical
Henan Universe
Ocular Therapeutix
PolyActiva
Health Guard Biomed
Key Questions Answered:
1. How big is the global Glaucoma Aqueous Shunt market?
2. What is the demand of the global Glaucoma Aqueous Shunt market?
3. What is the year over year growth of the global Glaucoma Aqueous Shunt market?
4. What is the production and production value of the global Glaucoma Aqueous Shunt market?
5. Who are the key producers in the global Glaucoma Aqueous Shunt market?
6. What are the growth factors driving the market demand?
Table of Contents
130 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
